Jaclyn Tilak

Associate

Email Twitter Facebook LinkedIn Google  More...

Jaclyn Tilak is an associate in the Litigation Group at Goodmans. Her practice focuses on commercial litigation, with an emphasis on intellectual property disputes.

Jaclyn has been counsel on a number of cases involving the Patented Medicines (Notice of Compliance) Regulations, and patent validity and infringement. Jaclyn has appeared before the Federal Court and the Federal Court of Appeal.

REPRESENTATIVE WORK

Jaclyn’s representative work includes acting for:

• Apotex Inc. in a successful challenge to the validity of a patent relating to the dosing of Eli Lilly’s ED medication (Eli Lilly v Apotex, 2020 FC 816)
• Apotex Inc. in a successful challenge to the validity and infringement of a patent relating to a process to make an intermediate of the active ingredient in Eli Lilly’s ED medication (Eli Lilly v Apotex, 2020 FC 814)
• Evolution Technologies Inc. in a successful appeal of a trial judgment enjoining the sale of Evolution’s mobility-aiding walkers and awarding financial remedies on account of patent infringement (Evolution Technologies v Human Care Canada, 2019 FCA 209)
• Evolution Technologies Inc. in successfully staying a trial judgment awarding financial remedies, pending the outcome of an appeal (Evolution Technologies v Human Care Canada, 2019 FCA 11)
• Apotex Inc. in patent infringement actions and actions under the Patented Medicines (Notice of Compliance) Regulations

PRO BONO

Jaclyn volunteers with Pro Bono Ontario, providing summary legal advice to Ontarians in need.

RECOGNITION

Jaclyn is recognized as a “Rising Star” in the area of Intellectual Property by The Legal 500 Canada.